Co-Authors
This is a "connection" page, showing publications co-authored by Luke Moore and Paul Randell.
Connection Strength
0.919
-
Optimising the initial investigation of suspected cases of SARS-CoV-2 reinfection. Travel Med Infect Dis. 2021 Jul-Aug; 42:102078.
Score: 0.236
-
Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection. Lancet Infect Dis. 2021 05; 21(5):598-599.
Score: 0.231
-
Non-invasive saliva specimens for the diagnosis of COVID-19: caution in mild outpatient cohorts with low prevalence. Clin Microbiol Infect. 2020 Dec; 26(12):1711-1713.
Score: 0.223
-
Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis. J Infect. 2021 10; 83(4):452-457.
Score: 0.060
-
Detection of SARS-CoV-2 Antibodies in Kidney Transplant Recipients. J Am Soc Nephrol. 2020 12; 31(12):2753-2756.
Score: 0.057
-
Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study. Lancet Microbe. 2020 Nov; 1(7):e300-e307.
Score: 0.056
-
Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study. Lancet Respir Med. 2020 09; 8(9):885-894.
Score: 0.056